Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a five-day ointment improve sun-damaged skin? new study investigates

NCT ID NCT07657988

Recruiting now Disease control Sponsor: Avant Health LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows adults with actinic keratosis (precancerous sun-damaged spots) on the face who are already using tirbanibulin ointment as part of their regular care. Researchers want to see if the treatment improves overall skin appearance and texture over 57 days. Participants answer online surveys at the start and end of the study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tirbanibulin ointment (Klisyri)
What this could lead to
If effective, tirbanibulin could offer a convenient, short-course treatment to improve skin appearance and texture in people with actinic keratosis.
What could go wrong
This is a small, observational pilot study with only 30 participants and no comparison group, so results may not apply to everyone. The treatment may not work as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

actinic keratosis Personal Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACTINIC KERATOSIS (AK)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ablon Skin Institute and Research Center

    RECRUITING

    Manhattan Beach, California, 90266, United States

  • Dermatology & Laser Center of Charleston

    RECRUITING

    Charleston, South Carolina, 29414, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.